Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 4

1(25.0%)

Phase 3

1(25.0%)

4Total

N/A(2)

Phase 4(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT03892148Phase 4Completed

Protocol of Diuretics Use in Congestive Therapy in Heart Failure

Role: collaborator

NCT05963061Recruiting

Chronic Myeloid Leukemia (CML) Real-Life Database

Role: collaborator

NCT03481868Not ApplicableRecruiting

EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors

Role: collaborator

NCT05149001Completed

Study Among People Living With HIV and Their Health Professionals of Associated Factors of Resilience to Self-stigma

Role: collaborator

NCT04671290Completed

Temocillin Versus Carbapenems for Urinary Tract Infection Due to ESBL-producing Enterobacteriaceae

Role: collaborator

NCT03972735Not ApplicableUnknown

Assessment of the Effectiveness of the NECT Program

Role: collaborator

NCT02736812Phase 3Completed

Pre-hospital Administration of Lyophilized Plasma for Post-traumatic Coagulopathy Treatment (PREHO-PLYO)

Role: collaborator

All 7 trials loaded